Cas no 19019-43-3 (Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt)
Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt Chemical and Physical Properties
Names and Identifiers
-
- Glycine,N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, sodium salt (1:3)
- trisodium,2-[2-[bis(carboxylatomethyl)amino]ethylamino]acetate
- Glycine,N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-,sodium salt (1:3)
- Glycine,N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-,trisodium salt
- trisodium 2,2'-({2-[(carboxylatomethyl)amino]ethyl}imino)diacetate
- trisodium 2-[2-[bis(2-oxido-2-oxoethyl)amino]ethylamino]acetate
- N-(Carboxymethyl)-N,N'-ethylenediglycine, trisodium salt
- Glycine, N-(carboxymethyl)-N-2-(carboxymethyl)aminoethyl-, trisodium salt
- n-(carboxymethyl)-n-[2-[(carboxymethyl)amino]ethyl]-glycin trisodium salt
- Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt
- Sodium 2,2'-((2-((carboxylatomethyl)amino)ethyl)azanediyl)diacetate
- Glycine, N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, trisodium salt
- Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, sodium salt (1:3)
- Trisodium ethylenediaminetriacetate
- Glycine, N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, sodium salt (1:3)
- trisodium 2,2'-({2-[(carb
- FT-0775267
- 19019-43-3
- DTXSID1049809
- Trisodium ethylenediamine triacetate
- Glycine,N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-,sodium salt(1:3)
- trisodium;2-[2-[bis(carboxylatomethyl)amino]ethylamino]acetate
- Sodium2,2'-((2-((carboxylatomethyl)amino)ethyl)azanediyl)diacetate
- WLMMGNLFDSJGOG-UHFFFAOYSA-K
-
- MDL: MFCD32661401
- Inchi: 1S/C8H14N2O6.3Na/c11-6(12)3-9-1-2-10(4-7(13)14)5-8(15)16;;;/h9H,1-5H2,(H,11,12)(H,13,14)(H,15,16);;;/q;3*+1/p-3
- InChI Key: WLMMGNLFDSJGOG-UHFFFAOYSA-K
- SMILES: [Na+].[Na+].[Na+].[O-]C(CN(CC(=O)[O-])CCNCC(=O)[O-])=O
Computed Properties
- Exact Mass: 300.03100
- Monoisotopic Mass: 300.03101892g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 8
- Heavy Atom Count: 19
- Rotatable Bond Count: 6
- Complexity: 235
- Covalently-Bonded Unit Count: 4
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 136
Experimental Properties
- PSA: 135.66000
- LogP: -5.48140
Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | G908464-100mg |
Glycine, N-(carboxymethyl)-N-2-(carboxymethyl)aminoethyl-, trisodium salt |
19019-43-3 | 95% | 100mg |
¥3,460.00 | 2022-01-10 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | G908464-25mg |
Glycine, N-(carboxymethyl)-N-2-(carboxymethyl)aminoethyl-, trisodium salt |
19019-43-3 | 95% | 25mg |
¥1,086.00 | 2022-01-10 | |
| eNovation Chemicals LLC | D768654-100mg |
Glycine, N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, sodium salt (1:3) |
19019-43-3 | 95% | 100mg |
$260 | 2024-06-07 | |
| eNovation Chemicals LLC | D768654-250mg |
Glycine, N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, sodium salt (1:3) |
19019-43-3 | 95% | 250mg |
$505 | 2024-06-07 | |
| 1PlusChem | 1P002EUZ-100mg |
Glycine, N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, sodium salt (1:3) |
19019-43-3 | 95% | 100mg |
$276.00 | 2024-06-17 | |
| 1PlusChem | 1P002EUZ-250mg |
Glycine, N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, sodium salt (1:3) |
19019-43-3 | 95% | 250mg |
$522.00 | 2024-06-17 | |
| Aaron | AR002F3B-100mg |
GLYCINE, N-(CARBOXYMETHYL)-N-[2-[(CARBOXYMETHYL)AMINO]ETHYL]-, SODIUM SALT (1:3) |
19019-43-3 | 95% | 100mg |
$260.00 | 2025-01-21 | |
| Aaron | AR002F3B-250mg |
GLYCINE, N-(CARBOXYMETHYL)-N-[2-[(CARBOXYMETHYL)AMINO]ETHYL]-, SODIUM SALT (1:3) |
19019-43-3 | 95% | 250mg |
$520.00 | 2025-01-21 | |
| A2B Chem LLC | AB11771-100mg |
Glycine, N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, sodium salt (1:3) |
19019-43-3 | 95% | 100mg |
$299.00 | 2024-04-20 | |
| A2B Chem LLC | AB11771-250mg |
Glycine, N-(carboxymethyl)-N-[2-[(carboxymethyl)amino]ethyl]-, sodium salt (1:3) |
19019-43-3 | 95% | 250mg |
$587.00 | 2024-04-20 |
Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt Related Literature
-
Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
-
Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
-
M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
Additional information on Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt
Research Brief on Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt (CAS: 19019-43-3)
Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt (CAS: 19019-43-3) is a specialized chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, often referred to as a trisodium salt derivative of glycine, is known for its chelating properties and its potential applications in drug formulation, metal ion sequestration, and biochemical assays. Recent studies have explored its role in enhancing the stability and bioavailability of therapeutic agents, making it a compound of interest for advanced pharmaceutical development.
The primary focus of recent research has been on the compound's ability to act as a chelating agent, particularly in the context of metal ion binding. Studies have demonstrated its efficacy in forming stable complexes with transition metals, which is crucial for applications in diagnostic imaging and targeted drug delivery systems. For instance, its use in contrast agents for magnetic resonance imaging (MRI) has shown promise due to its high affinity for gadolinium ions, which are commonly used in MRI contrast media. This property is attributed to the multiple carboxymethyl groups present in the molecule, which provide strong coordination sites for metal ions.
In addition to its chelating capabilities, Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt has been investigated for its role in improving the solubility and stability of poorly water-soluble drugs. Recent formulations incorporating this compound have shown enhanced dissolution rates and improved pharmacokinetic profiles, particularly for hydrophobic active pharmaceutical ingredients (APIs). This has significant implications for the development of oral dosage forms, where solubility is often a limiting factor in drug absorption and efficacy.
Another area of interest is the compound's potential use in biotechnology and enzyme stabilization. Researchers have reported that it can act as a stabilizing agent for enzymes and proteins, preventing denaturation and maintaining activity under harsh conditions. This makes it a valuable additive in industrial enzyme applications and diagnostic kits, where enzyme stability is critical for consistent performance. The trisodium salt form is particularly advantageous due to its high solubility and compatibility with aqueous systems.
Despite its promising applications, challenges remain in the large-scale synthesis and purification of Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt. Recent advancements in synthetic methodologies have focused on optimizing reaction conditions to improve yield and purity. Green chemistry approaches, such as the use of water as a solvent and catalytic methods, are being explored to reduce environmental impact and enhance sustainability in production processes.
In conclusion, Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt (CAS: 19019-43-3) represents a versatile compound with broad applications in pharmaceutical and biochemical research. Its chelating properties, solubility enhancement capabilities, and enzyme stabilization potential make it a valuable tool for drug development and biotechnology. Ongoing research aims to further elucidate its mechanisms of action and expand its utility in novel therapeutic and diagnostic applications.
19019-43-3 (Glycine, N-(carboxymethyl)-N-(2-((carboxymethyl)amino)ethyl)-, trisodium salt) Related Products
- 25102-12-9(DipotassiuM Dihydrogen EthylenediaMinetetraacetate Dihydrate)
- 869-52-3(3,6,9,12-Tetraazatetradecanedioic acid, 3,6,9,12-tetrakis(carboxymethyl)-)
- 17572-97-3(Tripotassium hydrogen ethylenediaminetetraacetate)
- 67-43-6(Pentetic acid)
- 65501-24-8(Ethylenediaminetetraacetic acid tripotassium salt dihydrate)
- 2001-94-7(Edetate dipotassium)
- 6381-92-6(Ethylenediaminetetraacetic acid disodium dihydrate)
- 304675-80-7(Diammonium Ethylenediaminetetraacetate Monohydrate)
- 20824-56-0(Ethylenediaminetetraacetic Acid Diammonium Salt)
- 15251-22-6(Acetic acid-d,(ethylenedinitrilo)tetra- (8CI))